Medline Inc (MDLN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Medline Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Based on dividend-adjusted daily data since Dec 17, 2025, MDLN's average daily return is +0.15%, while the average monthly return is +2.21%. At this rate, your investment would double in approximately 2.6 years.

Historically, 75% of months were positive and 25% were negative. The best month was Feb 2026 with a return of +7.5%, while the worst month was Mar 2026 at -6.3%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 1 months.

On a daily basis, MDLN closed higher 51% of trading days. The best single day was Jan 22, 2026 with a return of +6.1%, while the worst single day was Dec 29, 2025 at -4.8%.

Medline Inc has an annualized alpha of 55.78%, beta of 0.69, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since December 18, 2025.

• This stock captured 270.46% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -13.52%) — a profile typical of hedging or uncorrelated assets.
• Beta of 0.69 may look defensive, but with R² of 0.05 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

The table below present risk-adjusted performance metrics for Medline Inc (MDLN) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Medline Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medline Inc was 17.84%, occurring on Mar 12, 2026. The portfolio has not yet recovered.

The current Medline Inc drawdown is 10.98%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Medline Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Medline Inc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.